151 related articles for article (PubMed ID: 23649653)
21. The polymorphism of methylenetetrahydrofolate reductase C677T but not A1298C contributes to gastric cancer.
Lv L; Wang P; Sun B; Chen G
Tumour Biol; 2014 Jan; 35(1):227-37. PubMed ID: 23897558
[TBL] [Abstract][Full Text] [Related]
22. MTHFR C677T polymorphism contributes to colorectal cancer susceptibility: evidence from 61 case-control studies.
Sheng X; Zhang Y; Zhao E; Lu S; Zheng X; Ge H; Lu W
Mol Biol Rep; 2012 Oct; 39(10):9669-79. PubMed ID: 22729883
[TBL] [Abstract][Full Text] [Related]
23. Association of methylenetetrahydrofolate reductase (MTHFR) gene C677T polymorphism with autism: evidence of genetic susceptibility.
Rai V
Metab Brain Dis; 2016 Aug; 31(4):727-35. PubMed ID: 26956130
[TBL] [Abstract][Full Text] [Related]
24. MTHFR gene polymorphisms in bladder cancer in the Turkish population.
Izmirli M; Inandiklioglu N; Abat D; Alptekin D; Demirhan O; Tansug Z; Bayazit Y
Asian Pac J Cancer Prev; 2011; 12(7):1833-5. PubMed ID: 22126575
[TBL] [Abstract][Full Text] [Related]
25. Genetic susceptibility of methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C, and G1793A polymorphisms with risk for bladder transitional cell carcinoma in men.
Safarinejad MR; Shafiei N; Safarinejad S
Med Oncol; 2011 Dec; 28 Suppl 1():S398-412. PubMed ID: 21046286
[TBL] [Abstract][Full Text] [Related]
26. MTHFR C677T polymorphism and pancreatic cancer risk: a meta-analysis.
Liu XM; Liu FH; Tang Y; Li Q
Asian Pac J Cancer Prev; 2012; 13(8):3763-6. PubMed ID: 23098468
[TBL] [Abstract][Full Text] [Related]
27. Correlations between methylenetetrahydrofolate reductase gene polymorphisms and venous thromboembolism: A meta-analysis of 99 genetic association studies.
Zeng J; Zeng Q
Eur J Prev Cardiol; 2019 Jan; 26(2):120-134. PubMed ID: 30466296
[TBL] [Abstract][Full Text] [Related]
28. MTHFR Ala222Val polymorphism and clinical characteristics confer susceptibility to suicide attempt in chronic patients with schizophrenia.
Liu JH; Zhu C; Zheng K; Tang W; Gao LL; Trihn TH; Emily Wu H; Chen DC; Hong Xiu M; Yang Zhang X
Sci Rep; 2020 Mar; 10(1):5008. PubMed ID: 32193498
[TBL] [Abstract][Full Text] [Related]
29. Lack of association between MHTFR Glu429Ala polymorphism and breast cancer susceptibility: a systematic review and meta-analysis of 29 research studies.
Jiao Z; Li D
Tumour Biol; 2013 Apr; 34(2):1225-33. PubMed ID: 23393023
[TBL] [Abstract][Full Text] [Related]
30. Lack of association between MTHFR C677T Gene polymorphism with alcohol dependence: A meta-analysis of case-control studies.
Xu R; Wu H; Zhang S; Zhou H; Liang L
Neurosci Lett; 2018 Sep; 683():69-74. PubMed ID: 29953924
[TBL] [Abstract][Full Text] [Related]
31. Association between MTHFR 677C>T polymorphism and risk of gliomas: evidence from a meta-analysis.
Lu Q; Dai D; Zhao W; Wang L; Yue Z; Chen X; Han G; Hao B; Yang P; Deng A; Liu J
Tumour Biol; 2013 Oct; 34(5):2801-7. PubMed ID: 23765760
[TBL] [Abstract][Full Text] [Related]
32. The association between MTHFR C677T polymorphism and ovarian cancer risk: a meta-analysis of 18,628 individuals.
Ma C; Liu Y; Zhang W; Liu P
Mol Biol Rep; 2013 Mar; 40(3):2061-8. PubMed ID: 23329275
[TBL] [Abstract][Full Text] [Related]
33. Association between MTHFR C677T Polymorphism and Risk of Prostate Cancer: Evidence from 22 Studies with 10,832 Cases and 11,993 Controls.
Abedinzadeh M; Zare-Shehneh M; Neamatzadeh H; Abedinzadeh M; Karami H
Asian Pac J Cancer Prev; 2015; 16(11):4525-30. PubMed ID: 26107198
[TBL] [Abstract][Full Text] [Related]
34. Associations of the MTHFR rs1801133 polymorphism with coronary artery disease and lipid levels: a systematic review and updated meta-analysis.
Luo Z; Lu Z; Muhammad I; Chen Y; Chen Q; Zhang J; Song Y
Lipids Health Dis; 2018 Aug; 17(1):191. PubMed ID: 30115070
[TBL] [Abstract][Full Text] [Related]
35. Association of FOLH1, DHFR, and MTHFR gene polymorphisms with susceptibility of Neural Tube Defects: A case control study from Eastern India.
Paul S; Sadhukhan S; Munian D; Bankura B; Das M
Birth Defects Res; 2018 Aug; 110(14):1129-1138. PubMed ID: 30120883
[TBL] [Abstract][Full Text] [Related]
36. Cumulative review and meta-analyses on the association between MTHFR rs1801133 polymorphism and breast cancer risk: a pooled analysis of 83 studies with 74,019 participants.
Zhang Y; Jia H; Wang S; Jiang D
Minerva Med; 2017 Feb; 108(1):57-73. PubMed ID: 27824246
[TBL] [Abstract][Full Text] [Related]
37. Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study.
Lin J; Spitz MR; Wang Y; Schabath MB; Gorlov IP; Hernandez LM; Pillow PC; Grossman HB; Wu X
Carcinogenesis; 2004 Sep; 25(9):1639-47. PubMed ID: 15117811
[TBL] [Abstract][Full Text] [Related]
38. Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and susceptibility for cervical lesions: a meta-analysis.
Long S; Yang X; Liu X; Yang P
PLoS One; 2012; 7(12):e52381. PubMed ID: 23285018
[TBL] [Abstract][Full Text] [Related]
39. Methylenetetrahydrofolate reductase (MTHFR) polymorphism increases the risk of cervical intraepithelial neoplasia.
Piyathilake CJ; Macaluso M; Johanning GL; Whiteside M; Heimburger DC; Giuliano A
Anticancer Res; 2000; 20(3A):1751-7. PubMed ID: 10928104
[TBL] [Abstract][Full Text] [Related]
40. Association of MTHFR 677C>T Polymorphism with Susceptibility to Ovarian and Cervical Cancers: A Systematic Review and Meta-Analysis.
Karimi-Zarchi M; Moghimi M; Abbasi H; Hadadan A; Salimi E; Morovati-Sharifabad M; Akbarian-Bafghi MJ; Zare-Shehneh M; Mosavi-Jarrahi A; Neamatzadeh H
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2569-2577. PubMed ID: 31554347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
